This provider's $4.6M in total Medicare payments ranks in the 96th percentile of Hematology-Oncology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $195.75 | $78.10 | 2.51x | $117.65 | $562.0K | 12.9K | 4.0K |
| 2015 | $233.89 | $96.67 | 2.42x | $137.22 | $691.3K | 14.0K | 4.2K |
| 2016 | $189.69 | $72.64 | 2.61x | $117.05 | $716.1K | 16.2K | 4.9K |
| 2017 | $197.99 | $76.69 | 2.58x | $121.30 | $586.8K | 13.5K | 3.9K |
| 2018 | $116.74 | $33.97 | 3.44x | $82.77 | $380.2K | 11.0K | 3.5K |
| 2019 | $122.37 | $34.94 | 3.50x | $87.43 | $462.8K | 13.2K | 3.8K |
| 2020 | $102.40 | $28.25 | 3.62x | $74.15 | $320.7K | 11.5K | 3.5K |
| 2021 | $135.02 | $31.84 | 4.24x | $103.18 | $276.4K | 9.0K | 3.2K |
| 2022 | $110.92 | $32.53 | 3.41x | $78.39 | $313.7K | 10.2K | 3.2K |
| 2023 | $128.01 | $33.25 | 3.85x | $94.76 | $273.1K | 8.9K | 2.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 12.5K | $1.0M | $82.41 | 4.04x |
| J2505 | Injection, pegfilgrastim, 6 mg | 211 | $612.8K | $2.9K | 1.85x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 5.6K | $581.6K | $104.05 | 4.07x |
| G9678 | Oncology Care Model service | 2.2K | $338.2K | $156.80 | 1.03x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 4.3K | $227.7K | $52.39 | 4.13x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 14.8K | $134.1K | $9.07 | 1.80x |
| 80053 | Blood test, comprehensive group of blood chemicals | 10.6K | $127.1K | $12.05 | 2.50x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 865 | $102.5K | $118.50 | 4.09x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 612 | $94.7K | $154.75 | 3.73x |
| J9310 | Injection, rituximab, 100 mg | 158 | $91.8K | $580.93 | 1.72x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 1.8K | $89.2K | $50.74 | 4.51x |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 5.1K | $77.8K | $15.25 | 4.04x |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 473 | $74.5K | $157.47 | 3.41x |
| J9999 | Not otherwise classified, antineoplastic drugs | 132 | $70.6K | $534.53 | 1.76x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 1.3K | $64.1K | $49.77 | 4.01x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 1.1K | $59.5K | $56.13 | 4.60x |
| 36415 | Insertion of needle into vein for collection of blood sample | 13.9K | $47.0K | $3.39 | 2.52x |
| 96411 | Infusion of different chemotherapy drug or substance into a vein | 726 | $33.6K | $46.25 | 3.98x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 268 | $31.3K | $116.61 | 4.13x |
| 82728 | Ferritin (blood protein) level | 2.0K | $31.2K | $15.39 | 2.65x |
This provider submits charges 3.22 times higher than what Medicare actually pays.
A markup ratio of 3.22x means for every $100 Medicare pays, this provider initially charges $322. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data